share_log

Truist Securities:维持Coherus BioSciences(CHRS.US)评级,由买入调整至买入评级, 目标价由8.00美元调整至7.00美元。

Zhitong Finance ·  May 13 08:26

Truist Securities:维持Coherus BioSciences(CHRS.US)评级,由买入调整至买入评级, 目标价由8.00美元调整至7.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment